Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1957 2
1960 1
1965 1
1966 2
1968 1
1969 1
1970 1
1971 3
1973 1
1974 2
1975 4
1976 83
1977 128
1978 111
1979 152
1980 417
1981 859
1982 908
1983 804
1984 840
1985 764
1986 1069
1987 842
1988 1079
1989 1217
1990 1520
1991 1410
1992 1630
1993 1645
1994 1683
1995 1731
1996 1773
1997 1848
1998 1984
1999 2075
2000 2125
2001 2102
2002 2390
2003 2596
2004 2828
2005 3355
2006 3840
2007 4301
2008 4899
2009 5103
2010 5700
2011 6561
2012 6747
2013 7138
2014 7498
2015 7476
2016 7310
2017 6959
2018 7287
2019 7419
2020 7904
2021 8449
2022 7579
2023 6961
2024 1925

Text availability

Article attribute

Article type

Publication date

Search Results

142,790 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Stankevieiene
Page 1
Did you mean nida stankeviciene (1 results)?
Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Kibaly C, Alderete JA, Liu SH, Nasef HS, Law PY, Evans CJ, Cahill CM. Kibaly C, et al. Cell Mol Neurobiol. 2021 Jul;41(5):899-926. doi: 10.1007/s10571-020-01013-y. Epub 2020 Nov 27. Cell Mol Neurobiol. 2021. PMID: 33245509 Free PMC article. Review.
It is estimated that nearly a third of people who abuse drugs started with prescription opioid medicines. Approximately, 11.5 million Americans used prescription drugs recreationally in 2016, and in 2018, 46,802 Americans died as the result of an opioid overdose, including …
It is estimated that nearly a third of people who abuse drugs started with prescription opioid medicines. Approximately, 11.5 million …
The NIDA Avenir award in genetics or epigenetics of substance use disorders.
Satterlee JS, Pollock JD, Volkow ND. Satterlee JS, et al. Mol Cell Neurosci. 2023 Dec;127:103899. doi: 10.1016/j.mcn.2023.103899. Epub 2023 Sep 20. Mol Cell Neurosci. 2023. PMID: 37739148 Review.
NIDA's Avenir Program in the Genetics or Epigenetics of Substance Use Disorders (SUDs) was launched to support early stage investigators who propose innovative, high risk, but potentially high impact research and who show promise of being tomorrow's leaders in this scienti …
NIDA's Avenir Program in the Genetics or Epigenetics of Substance Use Disorders (SUDs) was launched to support early stage investigat …
Are we compulsively chasing rainbows?
George O, Ahmed SH, Gilpin NW. George O, et al. Neuropsychopharmacology. 2022 Nov;47(12):2013-2015. doi: 10.1038/s41386-022-01419-w. Epub 2022 Aug 18. Neuropsychopharmacology. 2022. PMID: 35982236 Free PMC article. Review. No abstract available.
Leaving the banquet.
Anderson D. Anderson D. Addict Sci Clin Pract. 2011 Jul;6(1):3. Addict Sci Clin Pract. 2011. PMID: 22003416 Free PMC article. No abstract available.
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic.
Tai B, Dobbins R, Blackeney Q, Liu D, Moran L. Tai B, et al. Addict Sci Clin Pract. 2021 May 8;16(1):28. doi: 10.1186/s13722-021-00238-6. Addict Sci Clin Pract. 2021. PMID: 33964973 Free PMC article.
Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a nationwide conso …
Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the Nationa …
A mapping review of NIDA-funded implementation research studies on treatments for opioid and/or stimulant use disorders.
Cheng H, Chokron Garneau H, Yuan M, McGovern MP. Cheng H, et al. Drug Alcohol Depend. 2021 Aug 1;225:108767. doi: 10.1016/j.drugalcdep.2021.108767. Epub 2021 May 21. Drug Alcohol Depend. 2021. PMID: 34052689 Free PMC article. Review.
This study assessed how implementation research has been deployed in the National Institute on Drug Abuse (NIDA) efforts to address the opioid and stimulant epidemics. ...RESULTS: An initial search across NIH institutes yielded 5963 relevant rec …
This study assessed how implementation research has been deployed in the National Institute on Drug Abuse (NI …
Harm reduction.
Normand J, Li JH, Thomson N, Jarlais DD. Normand J, et al. J Food Drug Anal. 2013 Oct;21(4):S10-S12. doi: 10.1016/j.jfda.2013.09.022. J Food Drug Anal. 2013. PMID: 25278732 Free PMC article.
Jacques Normand, Director of the AIDS Research Program of the U.S. National Institute on Drug Abuse. The three presenters (and their presentation topics) were: Dr. ...
Jacques Normand, Director of the AIDS Research Program of the U.S. National Institute on Drug Abuse …
Introducing the National Drug Early Warning System.
Artigiani EE, Wish ED. Artigiani EE, et al. Curr Opin Psychiatry. 2020 Jul;33(4):319-325. doi: 10.1097/YCO.0000000000000610. Curr Opin Psychiatry. 2020. PMID: 32250985 Free PMC article. Review.
PURPOSE OF REVIEW: In 2013, NIH NIDA released a special funding opportunity to update and expand their longstanding Community Epidemiology Workgroup (CEWG) by creating a coordinating center for a new type of monitoring system that became the National Drug Ear …
PURPOSE OF REVIEW: In 2013, NIH NIDA released a special funding opportunity to update and expand their longstanding Community Epidemi …
Sponsor's foreword: NIDA at forty.
Shurtleff D, Sasek C, Kautz M. Shurtleff D, et al. Neuropharmacology. 2014 Jan;76 Pt B:195-7. doi: 10.1016/j.neuropharm.2013.08.020. Epub 2013 Aug 28. Neuropharmacology. 2014. PMID: 23994442 No abstract available.
142,790 results
You have reached the last available page of results. Please see the User Guide for more information.